{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2017", "item": "https://www.patentleaderboard.com/2017/"}, {"@type": "ListItem", "position": 3, "name": "Sanofi", "item": "https://www.patentleaderboard.com/2017/company/sanofi"}, {"@type": "ListItem", "position": 4, "name": "Torsten Haack", "item": "https://www.patentleaderboard.com/2017/inventor/fl:to_ln:haack-2"}]}

Home › 2017 › Sanofi › Torsten Haack

TH

Torsten Haack — 9 Patents in 2017

SASanofi: 9 patents #3 of 232Top 2%

Frankfurt am Main, DE: #5 of 222 inventorsTop 3%

Overall (2017): #8,168 of 506,227Top 2%

9 Patents 2017

Issued Patents 2017

Showing 1–9 of 9 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
9789165	Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists	Dieter Kadereit, Katrin Lorenz, Andreas Evers, Michael Wagner, Bernd Henkel +2 more	2017-10-17	$7,245,000
9775904	Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists	Martin Bossart, Ralf Elvert, Andreas Evers, Siegfried Stengelin, Michael Wagner	2017-10-03	$8,333,000
9771406	Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4	Martin Bossart, Ralf Elvert, Andreas Evers, Siegfried Stengelin, Michael Wagner +1 more	2017-09-26	$18,404,000
9758561	Dual GLP-1/glucagon receptor agonists derived from exendin-4	Martin Bossart, Ralf Elvert, Andreas Evers, Siegfried Stengelin, Michael Wagner +1 more	2017-09-12	$14,166,000
9751926	Dual GLP-1/GIP receptor agonists	Dieter Kadereit, Katrin Lorenz, Andreas Evers, Michael Wagner, Bernd Henkel +2 more	2017-09-05	$7,330,000
9750788	Non-acylated exendin-4 peptide analogues	Dieter Kadereit, Katrin Lorenz, Andreas Evers, Michael Wagner, Bernd Henkel +2 more	2017-09-05	$7,330,000
9745360	Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists	Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more	2017-08-29	$18,132,000
9694053	Dual GLP-1/glucagon receptor agonists	Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Bossart +1 more	2017-07-04
9670261	Functionalized exendin-4 derivatives	Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers, Martin Lorenz +1 more	2017-06-06	$14,464,000